My Profile
Agnes Crane
Making a market in
Ideas
See all posts
Mon 23 Nov 2009 | 21:34 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Alkermes, Inc.
Alkermes, Inc. (ALKS.O) (Nasdaq)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
ALKS
on other exchanges
As of 23 Nov 2009
8.65
USD
Price Change
-0.01
Percent Change
-0.12%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Biberstein, Kathryn
50
2007
Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
Ehrich, Elliot
50
2007
Senior Vice President - Research and Development, Chief Medical Officer
Landine, Michael
55
2007
Senior Vice President - Corporate Development
Breyer, Robert
65
2001
Director
Bloom, Floyd
72
1987
Director
Rich, Alexander
84
1987
Director
Henwood, Geraldine
56
2003
Director
Mitchell, Paul
56
2003
Director
Skaletsky, Mark
61
2004
Director
Anstice, David
61
2008
Director
Pugh, Gordon
51
2007
Chief Operating Officer, Senior Vice President
Frates, James
42
2007
Chief Financial Officer, Senior Vice President, Treasurer
Pops, Richard
47
2009
Chairman of the Board, President, Chief Executive Officer
Wall, Michael
80
2007
Chairman Emeritus
Find out more about ALKS.O
Insider Trading